The average one-year price target for IQM Quantum Computers Oyj - Depositary Receipt (NASDAQGS:IQMX) (DB:561) has been revised to $16.58 / share. This is an increase of 30.00% from the prior estimate of $12.75 dated September 11, 2026. These figures represent aggregate analyst ta
The average one-year price target for Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) has been revised to $0.13 / share, up 19.98% from the prior estimate of $0.11 dated September 13, 2026. These figures represent aggregate analyst targets compiled by Fint
(RTTNews) - Nanobiotix S.A. (NBTX), a late-stage clinical biotechnology company developing physics-based nano-therapeutics for cancer and other major diseases, announced the appointment of Arnd Christ as Chief Financial Officer (CFO) and a member of its executive board.
(RTTNews) - Addex Therapeutics Ltd. (ADXN), a clinical-stage biopharmaceutical company, on Friday announced the appointment of Jean-Phillippe Rocher as the Head of Pharmaceutical Development, and a member of the Executive Management.
The average one-year price target for TruGolf Holdings (NASDAQCM:TRUG) has been revised to $61.20 / share. This is an increase of 900.00% from the prior estimate of $6.12 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not con
(RTTNews) - Daiichi Sankyo (4568.TS) and AstraZeneca (AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics (SMMT) to evaluate Datroway (datopotamab deruxtecan) in combination with ivonescimab across multiple solid tumor types, expanding efforts
(RTTNews) - Boeing's (BA) engineers and technical employees have approved a new four-year contract, their union said, removing the threat of another strike at the aviation giant.
(RTTNews) - The following biotech stocks reached a 52-week high on October 1, 2026, driven by key catalysts such as promising results from clinical trials or revised financial guidance.
Corn futures were fighting to stay above $5 for much of the session despite hitting a low of $4.95 in the December contract. Bulls battled back to close with contracts steady to 1 ½ cents higher. The CmdtyView national average Cash Corn price was up 3 1/4 cents at $4.61...
The average one-year price target for Charles River Laboratories International (NYSE:CRL) (BMV:CRL) has been revised to $307.39 / share, up 11.46% from the prior estimate of $275.80 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and
The average one-year price target for Universal Technical Institute (NYSE:UTI) (DB:UTI) has been revised to $37.59 / share. This is a decrease of 11.95% from the prior estimate of $42.69 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Finte
(RTTNews) - S&P Dow Jones Indices have announced the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600. Vylor Inc. (VYLR) was added to the S&P 500 on October 1, when S&P 500 constituent Corteva Inc. (CTVA) spun off Vylor.
(RTTNews) - Sweco AB (SWEC-B.ST, SWEC-A.ST), an architecture and engineering consultancy, on Friday announced that President and CEO Åsa Bergman has resigned from her position and will leave the company.
(RTTNews) - Daiichi Sankyo (4568.TS) and AstraZenca (AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics (SMMT) to evaluate Datroway (datopotamab deruxtecan) in combination with ivonescimab across multiple solid tumors, including lung and brea
Checked
21 minutes 48 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article